Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Purpura, Thrombocytopenic, Autoimmune”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01437384
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Eisai Inc. 36
Testing effectiveness (Phase 2)Study completedNCT04217148
What this trial is testing

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 132
Not applicableEnded earlyNCT04904276
What this trial is testing

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Who this might be right for
ITPImmune Thrombocytopenia
Rigel Pharmaceuticals 16
Early research (Phase 1)Looking for participantsNCT07072247
What this trial is testing

RN1201 Injection in the Treatment of Antibody-Mediated Diseases

Who this might be right for
Refractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 9
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Not applicableUnknownNCT03377439
What this trial is testing

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 400
Large-scale testing (Phase 3)Ended earlyNCT04200456
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 33
Not applicableStudy completedNCT00005570
What this trial is testing

An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicImmune Thrombocytopenic Purpura
National Heart, Lung, and Blood Institute (NHLBI) 200
Not applicableWithdrawnNCT01276561
What this trial is testing

Single Incision Versus Standard Laparoscopic Splenectomy

Who this might be right for
Hereditary SpherocytosisIdiopathic Thrombocytopenic Purpura
Children's Mercy Hospital Kansas City
Testing effectiveness (Phase 2)Looking for participantsNCT07297563
What this trial is testing

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Testing effectiveness (Phase 2)Study completedNCT02402998
What this trial is testing

Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

Who this might be right for
Primacy Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 55
Post-approval studies (Phase 4)Study completedNCT02556814
What this trial is testing

Caffeic Acid Combining High-dose Dexamethasone in Management of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 214
Large-scale testing (Phase 3)Study completedNCT02334813
What this trial is testing

Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
University Hospital, Essen 26
Testing effectiveness (Phase 2)Looking for participantsNCT05599880
What this trial is testing

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Relapsed/Refractory Immune Thrombocytopenia
Seoul National University Hospital 29
Testing effectiveness (Phase 2)Study completedNCT02153060
What this trial is testing

An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shandong University 58
Not applicableLooking for participantsNCT07587723
What this trial is testing

A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag

Who this might be right for
Immune Thrombocytopenia
Novartis Pharmaceuticals 150
Large-scale testing (Phase 3)Study completedNCT05369208
What this trial is testing

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 19
Large-scale testing (Phase 3)Study completedNCT00440037
What this trial is testing

Open Label Extension Study of AMG 531 in Japanese Subjects With ITP

Who this might be right for
Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Kyowa Kirin Co., Ltd. 44
Large-scale testing (Phase 3)Active Not RecruitingNCT05325593
What this trial is testing

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 129
Testing effectiveness (Phase 2)Study completedNCT04669600
What this trial is testing

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)
Bioverativ, a Sanofi company 12
Next Page